Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Levodopa‐induced dyskinesias
Giovanni Fabbrini, Jonathan M. Brotchie, Francisco Grandas, et al.
Movement Disorders (2007) Vol. 22, Iss. 10, pp. 1379-1389
Closed Access | Times Cited: 445

Showing 1-25 of 445 citing articles:

Parkinson’s Disease in Women and Men: What’s the Difference?
Silvia Cerri, Liudmila Mus, Fabio Blandini
Journal of Parkinson s Disease (2019) Vol. 9, Iss. 3, pp. 501-515
Open Access | Times Cited: 577
Molecular mechanisms of L-DOPA-induced dyskinesia
Peter Jenner
Nature reviews. Neuroscience (2008) Vol. 9, Iss. 9, pp. 665-677
Closed Access | Times Cited: 500
Priorities in Parkinson's disease research
Wassilios G. Meissner, Mark Frasier, Thomas Gasser, et al.
Nature Reviews Drug Discovery (2011) Vol. 10, Iss. 5, pp. 377-393
Closed Access | Times Cited: 413
NMDA receptors in clinical neurology: excitatory times ahead
Lorraine V. Kalia, Suneil K. Kalia, Michael W. Salter
The Lancet Neurology (2008) Vol. 7, Iss. 8, pp. 742-755
Open Access | Times Cited: 408
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
Valerie Voon, Pierre‐Olivier Fernagut, Jeffery R. Wickens, et al.
The Lancet Neurology (2009) Vol. 8, Iss. 12, pp. 1140-1149
Closed Access | Times Cited: 288
Development of allosteric modulators of GPCRs for treatment of CNS disorders
Hilary Highfield Nickols, P. Jeffrey Conn
Neurobiology of Disease (2013) Vol. 61, pp. 55-71
Open Access | Times Cited: 216
Striatal cholinergic interneuron regulation and circuit effects
Sean Austin O. Lim, Un Jung Kang, Daniel S. McGehee
Frontiers in Synaptic Neuroscience (2014) Vol. 6
Open Access | Times Cited: 206
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
M. Angela Cenci
Frontiers in Neurology (2014) Vol. 5
Open Access | Times Cited: 202
Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease
Santiago Perez‐Lloret, Francisco J. Barrantes
npj Parkinson s Disease (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 183
Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson’s disease
Rob Powers, Maryam Etezadi‐Amoli, Edith M. Arnold, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 579
Open Access | Times Cited: 161
Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
Destany K. Kwon, Mohit Kwatra, Jing Wang, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3736-3736
Open Access | Times Cited: 78
D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease
M.L. Paul, Ann M. Graybiel, J.-C. David, et al.
Journal of Neuroscience (1992) Vol. 12, Iss. 10, pp. 3729-3742
Open Access | Times Cited: 300
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
Bhomraj Thanvi, Nelson Lo, Thompson Robinson
Postgraduate Medical Journal (2007) Vol. 83, Iss. 980, pp. 384-388
Open Access | Times Cited: 252
The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
Christopher G. Goetz, John G. Nutt, Glenn T. Stebbins
Movement Disorders (2008) Vol. 23, Iss. 16, pp. 2398-2403
Closed Access | Times Cited: 224
Maladaptive striatal plasticity in l-DOPA-induced dyskinesia
M. Angela Cenci, Christine Konradi
Progress in brain research (2010), pp. 209-233
Open Access | Times Cited: 196
L-dopa therapy for Parkinson's disease: Past, present, and future
Toshiharu Nagatsu, Makoto Sawada
Parkinsonism & Related Disorders (2009) Vol. 15, pp. S3-S8
Closed Access | Times Cited: 193
Parkinson's disease and resistive exercise: Rationale, review, and recommendations
Michael J. Falvo, Brian K. Schilling, Gammon M. Earhart
Movement Disorders (2007) Vol. 23, Iss. 1, pp. 1-11
Open Access | Times Cited: 189
The serotonergic system in Parkinson's disease
Philippe Huot, Susan H. Fox, Jonathan M. Brotchie
Progress in Neurobiology (2011) Vol. 95, Iss. 2, pp. 163-212
Closed Access | Times Cited: 182
AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials
Daniela Berg, Jana Godau, Claudia Trenkwalder, et al.
Movement Disorders (2011) Vol. 26, Iss. 7, pp. 1243-1250
Closed Access | Times Cited: 171
L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission
Michael Feyder, Alessandra Bonito-Oliva, Gilberto Fisone
Frontiers in Behavioral Neuroscience (2011) Vol. 5
Open Access | Times Cited: 163
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
Javier Fernández‐Ruíz, Mariluz Hernández, J.A. Ramos
CNS Neuroscience & Therapeutics (2010) Vol. 16, Iss. 3
Open Access | Times Cited: 154
Levodopa-Induced-Dyskinesias Clinical Features, Incidence, Risk Factors, Management and Impact on Quality of Life
Alice J. Manson, Paola Stirpe, Anette Schrag
Journal of Parkinson s Disease (2012) Vol. 2, Iss. 3, pp. 189-198
Open Access | Times Cited: 151
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
Daniella Rylander Ottosson, Hanna Iderberg, Qin Li, et al.
Neurobiology of Disease (2010) Vol. 39, Iss. 3, pp. 352-361
Closed Access | Times Cited: 150
Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations
Philippe Huot, Tom H. Johnston, Tayyeba Darr, et al.
Movement Disorders (2010) Vol. 25, Iss. 10, pp. 1399-1408
Closed Access | Times Cited: 138
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study
Roberto Ceravolo, Giovanni Cossu, M. Poggio, et al.
Movement Disorders (2013) Vol. 28, Iss. 10, pp. 1391-1397
Closed Access | Times Cited: 137
Page 1 - Next Page

Scroll to top